Abstract
A neuroprotective compound designated pyroxazone (1) was isolated from the culture broth of Streptomyces sp. RAN54. The molecular formula of 1 was established as C18H14N2O5 by high-resolution FAB-MS. The structure was determined to be a new 2-amino-3H-phenoxazin-3-one derivative by NMR spectroscopic analysis. Pyroxazone (1) protected C6 rat glioma cells and N18-RE-105 rat primary retina-mouse neuroblastoma hybrid cells from glutamate-induced toxicity with EC50s of 8.2 µM and 1.7 µM, respectively.
Cerebral ischemic diseases are one of the leading causes of death and long-term adult disability. In brain ischemia, release of excess glutamate induces neuron depolarization and significant increase of intracellular calcium, which activates multiple death pathways [1]. Accumulation of extracellular glutamate also inhibits the cystine-glutamate exchanger, resulting in depletion of the intracellular antioxidant glutathione [2, 3]. Subsequently, reactive oxygen species are generated and implicated in neuronal cell death. C6 rat glioma cells display some neuronal characteristics and undergo cell death when exposed to glutamate [4, 5]. Thus, C6 cells are a good model for evaluating neuroprotective activity against glutamate-induced toxicity. In the course of our screening for neuroprotective compounds of microbial origin using C6 cells, a new active compound designated pyroxazone (1) was isolated from the culture broth of an actinomycete strain RAN54. This report describes the isolation, structure elucidation, and biological activity of 1.
Strain RAN54 was isolated from a soil sample collected at Mibu-machi, Shimotsuga-gun, Tochigi Prefecture, Japan. The 16S rRNA gene fragment was amplified by PCR and sequenced [6]. The sequence displayed high similarity to Streptomyces tendae ATCC 19812 (99.3%) and Streptomyces tritolerans DAS 165 (99.1%). Accordingly, strain RAN54 was identified as a member of the genus Streptomyces and named Streptomyces sp. RAN54. The 16S rRNA gene sequence of Streptomyces sp. RAN54 has been deposited in the GenBank, DDBJ, and EMBL databases under accession number LC388337.
The producing organism was cultivated in 500-mL Erlenmeyer flasks containing 100 mL of a medium consisting of 2.5% glucose, 1.5% soybean meal (Nisshin Oillio Group, Tokyo, Japan), 0.2% dry yeast (Asahi Food and Healthcare, Tokyo, Japan) and 0.4% calcium carbonate (pH 6.2 before autoclaving). The fermentation was carried out at 27 °C for 4 days on a rotary shaker. The culture broth (1 L) was centrifuged and the mycelium was extracted with acetone. After evaporation, the aqueous concentrate was extracted with ethyl acetate at pH 3. The extract was chromatographed on a silica gel column with chloroform-methanol (100:1). The active fraction was evaporated and the dried material was washed with chloroform and methanol. The residue was dissolved in chloroform-methanol (10:1) and concentrated to dryness to give a pure orange powder of 1 (4.6 mg). The purified sample of 1 was readily soluble in dimethyl sulfoxide (DMSO) or alkaline methanol and slightly soluble in chloroform or methanol.
The physico-chemical properties of pyroxazone (1) were as follows. M.P. 288–291 °C (decomposition); FAB-MS m/z 339.0984 ([M + H]+, calcd. for C18H15N2O5, 339.0981); UV λmax (ε) 248 (23,800), 418 (25,700) nm in methanol; IR νmax 3255, 1732, 1659 cm−1.
The molecular formula of 1 was established as C18H14N2O5 by high-resolution FAB-MS. 13C and 1H NMR data for 1 in DMSO-d6 are summarized in Table 1. All one-bond 1H–13C connectivities were confirmed by an HMQC experiment. A COSY experiment revealed three proton sequences (H-1-H-2, H-8-H-9-H-10, and H-13-H-14) as shown in Fig. 1b. In the HMBC spectrum, the three ortho-coupled aromatic protons (H-8, H-9, and H-10) exhibited long-range correlations to six aromatic carbons (C-7a, C-8, C-9, C-10, C-11, and C-11a) to construct a 1,2,3-trisubstituted benzene ring. Long-range couplings from both H-1 and H-2 to C-3 and C-12b and from both H-13 and H-14 to C-11 and C-15 indicated the presence of two β-carbonylethyl groups located on C-11 and C-12b, respectively. One of the β-carbonylethyl moieties was part of a δ-lactam ring due to long-range correlations from an amide proton (H-4) to C-2 and C-12b. The second aromatic ring with a semi-quinone structure was required by long-range couplings from H-1 to C-4a and C-12a, from H-6 to C-4a, C-6a, and C-12a, and from H-4 to a carbonyl carbon (C-5). The orange color (λmax 418 nm) of 1 suggested conjugation of the two aromatic rings. The two low-field carbons (C-6a, δ 148.9; C-7a, δ 142.9) were joined by an ether linkage to generate a 2-amino-3H-phenoxazin-3-one chromophore. Finally, C-15 was attributed to a carboxylic acid group from the molecular formula and the acidity of 1, and this assignment completed the structure of 1 as shown in Fig. 1a.
A few types of antibiotics contain the 2-amino-3H-phenoxazin-3-one chromophore and they include questiomycin A [7, 8], actinomycins [9] and chandrananimycins [10]. Among them, only chandrananimycin C has the same tetracyclic skeleton as 1, and pyroxazone (1) is the first example of 2-amino-3H-phenoxazin-3-one derivatives bearing C3 substituents.
The neuroprotective activity of pyroxazone (1) was examined by the MTT method. Cell viability was measured as absorbance at 540 nm, after the cells were treated with 0.5 mg/mL of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) for 4 h. When C6 rat glioma cells were treated with 100 mM glutamate for 24 h, about 90% of the cells underwent cell death. Pyroxazone (1) protected C6 cells from glutamate toxicity with an EC50 of 8.2 µM. This compound also showed neuroprotective activity in N18-RE-105 rat primary retina-mouse neuroblastoma hybrid cells [11, 12]. The EC50 value of 1 was 1.7 µM in N18-RE-105 cells treated with 10 mM glutamate for 24 h. Further biological studies are now under way.
References
Taoufik E, Probert L. Ischemic neuronal damage. Curr Pharm Des. 2008;14:3565–73.
Murphy TH, Miyamoto M, Sastre A, Schnaar RL, Coyle JT. Glutamate toxicity in a neuronal cell line involves inhibition of cystine transport leading to oxidative stress. Neuron. 1989;2:1547–58.
Aoyama K, Watabe M, Nakaki T. Regulation of neuronal glutathione synthesis. J Pharmacol Sci. 2008;108:227–38.
Mawatari K, Yasui Y, Sugitani K, Takadera T, Kato S. Reactive oxygen species involved in the glutamate toxicity of C6 glioma cells via XC- antiporter system. Neuroscience. 1996;73:201–8.
Hayakawa Y, Kobayashi T, Izawa M. Indanostatin, a new neuroprotective compound from Streptomyces sp. J Antibiot. 2013;66:731–3.
Weisburg WG, Barns SM, Pelletier DA, Lane DJ. 16S ribosomal DNA amplification for phylogenetic study. J Bacteriol. 1991;173:697–703.
Anzai K, Isono K, Okuma K, Suzuki S. The new antibiotics, questiomycins A and B. J Antibiot. 1960;13:125–32.
Gerber NN, Lechevalier MP. Phenazines and phenoxazinones from Waksmania aerata sp. nov. and Pseudomonas iodina. Biochemistry. 1964;3:598–602.
Hollstein U. Actinomycin. Chemistry and mechanism of action. Chem Rev. 1974;74:625–52.
Maskey RP, Li FC, Qin S, Fiebig HH, Laatsch H. Chandrananimycins A-C: production of novel anticancer antibiotics from a marine Actinomadura sp. isolate M048 by variation of medium composition and growth conditions. J Antibiot. 2003;56:622–9.
Malouf AT, Schnaar RL, Coyle JT. Characterization of a glutamic acid neurotransmitter binding site on neuroblastoma hybrid cells. J Biol Chem. 1984;259:12756–62.
Shin-ya K, et al. Carquinostatin B, a new neuronal cell-protecting substance produced by Streptomyces exfoliatus. Biosci Biotech Biochem. 1997;61:1768–9.
Acknowledgements
We are grateful to Ms. F. Hasegawa for assistance with mass spectrometry.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Electronic supplementary material
Rights and permissions
About this article
Cite this article
Hayakawa, Y., Kuriyama, T., Ibusuki, Y. et al. Pyroxazone, a new neuroprotective compound from Streptomyces sp. RAN54. J Antibiot 71, 962–964 (2018). https://doi.org/10.1038/s41429-018-0085-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41429-018-0085-4